Kolon Biotech, Inc. announced that it will issue 147,000 common shares at an issue price of KRW 17,000 for gross proceeds of KRW 2,499,000,000 on October 18, 2022. The transaction included participation returning investor Kolon Life Science Inc. The transaction was approved board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
22,400 KRW | +0.22% | +1.13% | -12.84% |
1st Jan change | Capi. | |
---|---|---|
-12.84% | 187M | |
+31.06% | 682B | |
+30.35% | 586B | |
-3.42% | 364B | |
+18.02% | 327B | |
+4.27% | 285B | |
+15.53% | 240B | |
+10.16% | 209B | |
-8.14% | 203B | |
+8.12% | 165B |
- Stock Market
- Equities
- A102940 Stock
- News Kolon Life Science Inc.
- Kolon Biotech, Inc. announced that it expects to receive KRW 2.499 billion in funding from Kolon Life Science Inc.